Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
1.
ACG Case Rep J ; 11(1): e01241, 2024 Jan.
Article in English | MEDLINE | ID: mdl-38162008

ABSTRACT

Postbanding ulcer bleeds (PBUBs) are an uncommon complication of variceal band ligation. They are often treated with proton pump inhibitors in addition to endoscopic interventions such as epinephrine injections, hemostatic clips, electrothermal cautery, or further band ligation. Over-the-scope clips are being increasingly used for the management of acute nonvariceal upper gastrointestinal bleeds, but their use in the management of PBUBs has been reported only once before. We present a 24-year-old man with alcohol-associated decompensated cirrhosis with recurrent PBUB, despite multiple endoscopic interventions, transjugular intrahepatic portosystemic shunt, and liver transplant, treated successfully with an Ovesco clip.

2.
VideoGIE ; 7(12): 436-438, 2022 Dec.
Article in English | MEDLINE | ID: mdl-36467525

ABSTRACT

Video 1Endoscopic submucosal dissection of a tumor in the upper esophageal sphincter and piriform sinus.

3.
Dis Mon ; 66(1): 100849, 2020 Jan.
Article in English | MEDLINE | ID: mdl-30798984

ABSTRACT

Gastroesophageal reflux disease (GERD) continues to be one of the most prevalent gastrointestinal tract disorders. Management of GERD is individualized for each patient depending on severity of symptoms, complications of GERD and patient/physician preference. The different management options include life style modification, pharmacological therapy, minimally invasive procedures and surgery. The final decision regarding management should be made based on an individualized patient centered approach on a case-by-case basis in consultation with a multidisciplinary team including primary care physician, gastroenterologist and surgeon. We provide a comprehensive review for the management of GERD.


Subject(s)
Gastroesophageal Reflux/therapy , Anti-Ulcer Agents/therapeutic use , Endoscopy, Digestive System , Fundoplication , Gastroesophageal Reflux/classification , Histamine Antagonists/therapeutic use , Humans , Laparoscopy , Life Style , Postoperative Complications , Proton Pump Inhibitors/therapeutic use , Radiofrequency Therapy , Severity of Illness Index , Weight Loss
4.
Dis Mon ; 66(1): 100848, 2020 Jan.
Article in English | MEDLINE | ID: mdl-30803725

ABSTRACT

Gastroesophageal reflux disease (GERD) is one of the most common diseases encountered by both internists and gastroenterologists. GERD can cause a wide variety of symptoms ranging from heartburn and regurgitation to more atypical symptoms such as cough, chest pain, and hoarseness. The diagnosis is often times made on the basis of history and clinical symptomatology. The prevalence of GERD is currently estimated to be 8-33% with the incidence of disease only expected to increase over time. Although most cases of GERD can be diagnosed based on symptoms and clinical presentation, the diagnosis of GERD can be challenging when symptoms are atypical. In this review, we provide a comprehensive summary of the epidemiology, pathophysiology, evaluation and diagnosis of gastroesophageal reflux disease.


Subject(s)
Gastroesophageal Reflux/diagnosis , Asthma/etiology , Barium Sulfate , Contrast Media , Cough/etiology , Drug-Related Side Effects and Adverse Reactions , Endoscopy, Digestive System , Esophageal pH Monitoring , Female , Food/adverse effects , Gastroesophageal Reflux/physiopathology , Genetic Predisposition to Disease , Hernia, Hiatal/complications , Humans , Laryngitis/etiology , Manometry , Obesity/complications , Pregnancy , Pregnancy Complications , Proton Pump Inhibitors , Risk Factors , Smoking
5.
Dis Mon ; 66(1): 100850, 2020 Jan.
Article in English | MEDLINE | ID: mdl-30808502

ABSTRACT

Barrett's esophagus (BE) is characterized by a change in the mucosal lining of the distal esophagus whereby the squamous epithelium of the esophagus is replaced by the metaplastic columnar epithelium. It is a pre-malignant lesion associated with esophageal adenocarcinoma. Patients with gastroesophageal reflux disease who have additional risk factors (Caucasian race, male gender, age > 50 years, tobacco use, and central obesity) should undergo an esophagogastroduodenoscopy to screen for Barrett's esophagus. Patients with Barrett's esophagus should undergo endoscopic surveillance every 3-5 years if no dysplasia is found. Patients with Barrett's esophagus who are found to have dysplasia should be treated endoscopically. We present a comprehensive review of the pathophysiology, diagnosis, surveillance and management of Barrett's esophagus.


Subject(s)
Barrett Esophagus/diagnosis , Barrett Esophagus/therapy , Adenocarcinoma/etiology , Adenocarcinoma/therapy , Cryotherapy , Disease Progression , Esophageal Neoplasms/etiology , Esophageal Neoplasms/therapy , Esophagoscopy , Humans , Obesity/complications , Photochemotherapy , Proton Pump Inhibitors/therapeutic use , Radiofrequency Ablation , Risk Factors , Smoking/adverse effects , Watchful Waiting
6.
Dig Dis Sci ; 65(5): 1481-1488, 2020 05.
Article in English | MEDLINE | ID: mdl-31587154

ABSTRACT

INTRODUCTION: The 30-day hospital readmission rate is a nationally recognized quality measure. Nearly one-fifth of medicare beneficiaries are hospitalized within 30 days of discharge, resulting in a cost of over $26 billion dollars annually. Endoscopic retrograde cholangiopancreatography (ERCP) remains the endoscopic procedure with the highest risk of morbidity and mortality. We set out to analyze the clinical characteristics predictive of 30-day readmission after an inpatient ERCP. METHODS: We performed a retrospective chart review of all inpatient ERCPs performed at our institution between 12/1/2014 and 9/30/2018. Clinical characteristics and outcomes of these patients were compared to determine predictors of 30-day readmission. RESULTS: A total of 497 inpatient ERCP procedures done for biliary or pancreatic indications, constituting 483 patients, were identified. There were 52 readmissions that occurred among 48 patients within 30 days of discharge. Basic demographic characteristics were similar between both groups. Comorbidities were significantly higher in those who were readmitted. Multivariate analysis revealed significantly greater odds of readmission with prior liver transplantation (OR = 4.15), cirrhosis (OR = 3.20), and pancreatic duct stent placement (OR = 2.56). Subgroup analysis for biliary indications revealed cholecystectomy before discharge and early ERCP to be protective against readmission. CONCLUSION: A history of liver transplantation and cirrhosis are predictive of increased 30-day readmission rates after an inpatient ERCP. Pancreatic duct stent placement is associated with readmission; however, this phenomenon is likely related to stenting for pancreatic endotherapy. Cholecystectomy before discharge and early ERCP are predictive of decreased need for readmission in procedures done for biliary indications.


Subject(s)
Cholangiopancreatography, Endoscopic Retrograde/adverse effects , Inpatients/statistics & numerical data , Patient Readmission/statistics & numerical data , Postoperative Complications/etiology , Aged , Cholecystectomy/adverse effects , Female , Humans , Liver Transplantation/adverse effects , Male , Medicare/statistics & numerical data , Middle Aged , Pancreatic Ducts/surgery , Postoperative Complications/epidemiology , Retrospective Studies , Stents/adverse effects , United States/epidemiology
7.
Pancreas ; 48(10): 1386-1392, 2019.
Article in English | MEDLINE | ID: mdl-31688606

ABSTRACT

OBJECTIVES: We aimed to evaluate the prevalence, impact, and predictors of opioid use disorder (OUD) in hospitalized chronic pancreatitis (CP) patients. METHODS: A retrospective cohort study was performed using the National Inpatient Sample database from 2005 to 2014. Patients with a primary diagnosis of CP and OUD were included. The primary outcome was evaluating the prevalence and trend of OUD in patients hospitalized with CP. Secondary outcomes were to (1) assess the impact of OUD on health care resource utilization and (2) identify predictors of OUD in hospitalized CP patients. RESULTS: A total of 176,857 CP patients were included, and OUD was present in 3.8% of patients. The prevalence of OUD in CP doubled between 2005 and 2014. Patients with CP who had OUD were found to have higher mean length of stay (adjusted mean difference, 1.2 days; P < 0.001) and hospitalization costs (adjusted mean difference, US $1936; P < 0.001). Independent predictors of OUD in CP patients were obesity, presence of depression, and increased severity of illness. CONCLUSIONS: Opioid use disorder-related diagnoses are increasing among CP patients and are associated with increased health care resource utilization. Our study identifies patients at high-risk for OUD whose pain should be carefully managed.


Subject(s)
Opioid-Related Disorders/epidemiology , Pancreatitis, Chronic/drug therapy , Adolescent , Adult , Aged , Female , Health Resources , Hospitalization , Humans , Length of Stay , Male , Middle Aged , Prevalence , Retrospective Studies , Young Adult
8.
ACG Case Rep J ; 6(3): e00027, 2019 Mar.
Article in English | MEDLINE | ID: mdl-31620508

ABSTRACT

Although duodenal diverticula are relatively common, the bleeding complications from duodenal diverticula are exceedingly rare. We report 2 cases of obscure upper gastrointestinal bleeding secondary to angiodysplasias within a duodenal diverticula. These cases highlight the importance of considering duodenal diverticular angiodysplasias as a clinically significant etiology for upper gastrointestinal bleeding.

10.
World J Clin Cases ; 7(9): 1006-1020, 2019 May 06.
Article in English | MEDLINE | ID: mdl-31123673

ABSTRACT

Acute pancreatitis (AP) is one of the most common gastrointestinal causes for hospi-talization in the United States. In 2015, AP accounted for approximately 390000 hospitalizations. The burden of AP is only expected to increase over time. Despite recent advances in medicine, pancreatitis continues to be associated with a substantial morbidity and mortality. The most common cause of AP is gallstones, followed closely by alcohol use. The diagnosis of pancreatitis is established with any two of three following criteria: (1) Abdominal pain consistent with that of AP; (2) Serum amylase and/or lipase greater than three times the upper limit of normal; and (3) Characteristics findings seen in cross-sectional abdominal imaging. Multiple criteria and scoring systems have been established for assessing severity of AP. The cornerstones of management include aggressive intravenous hydration, appropriate nutrition and pain management. Endoscopic retrograde cholangiopancreatography and surgery are important aspects in management of acute gallstone pancreatitis. We provide a comprehensive review of evaluation and management of AP.

11.
SELECTION OF CITATIONS
SEARCH DETAIL
...